1. What can mutation lead trastuzumab resistance with lapatinib sensitivy from HER2+ cancers

An Illustrated Guide To Vet Med Term
4th Edition
ISBN:9781305465763
Author:ROMICH
Publisher:ROMICH
Chapter21: Hog Heaven
Section: Chapter Questions
Problem 20MC
icon
Related questions
Question

Please answer all questions 

1. What can mutation lead trastuzumab resistance with lapatinib sensitivy from HER2+ cancers. 

2. What can another oncogeneic mutation be which lets HER2+ tumors being positive, have resistance to the lapatanib

Expert Solution
Step 1

*NOTE: Kindly repost for other question. Dear Student as per the guidelines we are supposed to answer only one of the question. So please repost the question for getting the answers for others too thank you.

1.Lapatanib is a HER2 kinase inhibitor and it is used for people with over breast cancer who will have HER2 kinase in excessive as it will inhibit the HER2 kinase it is given to people with over breast cancer.

* JIMT-1 and MDA453 are the cells which possess PIK3CA mutation that is  resistance to trastuzumab also  reduced sensitivity to lapatinib. 

*So these mutations will cause sensitivity to lapatinib these will make it to sensitive to HER2+ cancers .

 

trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Mutation
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
An Illustrated Guide To Vet Med Term
An Illustrated Guide To Vet Med Term
Biology
ISBN:
9781305465763
Author:
ROMICH
Publisher:
Cengage